Clinical reviews

← vista completa

Published on August 1, 2012 | http://doi.org/10.5867/medwave.2012.07.5462

Metabolic surgery: gastric bypass and type 2 diabetes

Cirugía metabólica: bypass gástrico y diabetes tipo 2

Enrique Lanzarini

Abstract

Currently, type 2 diabetes mellitus and obesity behave as epidemic diseases. Medical treatment has not been able to achieve adequate metabolic control in a sufficient number of patients and is not exempt of complications. Meanwhile, the group of diabetics with severe and morbid obesity that have undergone bariatric surgery have mostly evolved with remission of their diabetes in the medium and long term, so that surgery has become the first choice of treatment. This early post operative remission is not explained by weight loss only, as other mechanisms linked to anatomic and functional changes mediated by surgery are under research. There is a great interest to explore new treatment options for type 2 diabetes including surgery in patients with mild to severe obesity, which has been denominated metabolic surgery.

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Enrique Lanzarini

Departamento de Cirugía, Hospital Clínico Universidad de Chile, Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Lanzarini E. Metabolic surgery: gastric bypass and type 2 diabetes. Medwave 2012;12(07):e5462 doi: 10.5867/medwave.2012.07.5462

Submission date 19/04/2012

Acceptance date 09/07/2012

Publication date 01/08/2012

Index

Metrics

Not available at the moment.

Notes

Keywords

metabolic surgery, diabetes mellitus, gastric bypass

Origin and peer review

con revisión externa por 2 revisores, a doble ciego

References

  1. Zimmet P. The burden of type 2 diabetes: are we doing enough? Diabetes Metab. 2003 Sep;29(4 Pt 2):6S9-18. | PubMed
  2. Wild S, Roglic G, Green A, Sicree R, King H. Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004 May;27(5):1047-53. | CrossRef | PubMed
  3. Donnelly R, Emslie-Smith AM, Gardner ID, Morris AD. ABC of arterial and venous disease: vascular complications of diabetes. BMJ. 2000 Apr 15;320(7241):1062-6. | CrossRef | PubMed
  4. Geiss L, Herman W, Smith P. Mortality in non insulin-dependent diabetes. En: Diabetes in America, 2nd edition. NIH Publication, 1995;95:1468.
  5. Haffner S, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from Coronary Heart Disease in subjects withType 2 Diabetes and in nondiabetic subjects with or without prior myocardial infarction. N Engl J Med. 1998 Jul 23;339(4):229-34. | CrossRef | PubMed
  6. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UP 34) Lancet. 1998 Sep 12;352(9131):854-65. | PubMed
  7. Heine R, Diamant M, Mbanya JC, Nathan D. Management of Hyperglycemia in Type 2 Diabetes: The End of Recurrent Failure? BMJ. 2006 Dec 9;333(7580):1200-4. | CrossRef | PubMed
  8. Dailey G, Kim MS, Lian JF. Patient Compliance and Persistence with Anti-Hyperglycemic Therapy: Evaluation of a Population of Type 2 Diabetic Patients. J Int Med Res. 2002 Jan-Feb;30(1):71-9. | PubMed
  9. Kahn S, Haffner S, Heise M, Herman W, Holman R, Jones N, et al. Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy. N Engl J Med. 2006 Dec 7;355(23):2427-43. Epub 2006 Dec 4. | CrossRef | PubMed
  10. Dormandy J, Charbonnel B, Eckland D, Erdmann E, Massi-Benedetti M, Moules I, et al. Secondary Prevention on Macrovascular Events in Patients with Type 2 Diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A Randomised Controlled Trial. Lancet. 2005 Oct 8;366(9493):1279-89. | CrossRef | PubMed
  11. Lago R, Singh P, Nesto R. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet. 2007 Sep 29;370(9593):1129-36. | CrossRef | PubMed
  12. Parks M, Rosenbraugh C. Weighing risks and benefits of liraglutide – the FDA’s review of a new anidiabetic therapy. N Engl J Med. 2010 Mar 4;362(9):774-7. Epub 2010 Feb 17. | CrossRef | PubMed
  13. Rubino F, Gagner M. Potential of surgery for curing type 2 diabetes mellitus. Ann Surg. 2002 Nov;236(5):554-9. | CrossRef | PubMed
  14. Rubino F, Schauer P, Kaplan L, Cummings D. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393-411. | CrossRef | PubMed
  15. Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007 Aug 23;357(8):741-52. | CrossRef | PubMed
  16. Sjöström L, Gummesson A, Sjöström CD, Narbro K, Peltonen M, Wedel H, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective controlled intervention trial. Lancet Oncol. 2009 Jul;10(7):653-62. Epub 2009 Jun 24. | CrossRef | PubMed
  17. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007 Aug 23;357(8):753-61. | CrossRef | PubMed
  18. Christou NV, Sampalis JS, Liberman N, Look D, Auger S, McLean AP, et al. Surgery decreases long-term mortality, morbidity and health care use in morbidly obese patients. Ann Surg. 2004 Sep;240(3):416-23; discussion 423-4. | CrossRef | PubMed
  19. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. | CrossRef | PubMed
  20. Schauer PR, Ikramuddin S, Gourash W, Ramanathan R, Luketich J. Outcomes after laparoscopic roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000 Oct;232(4):515-29. | CrossRef | PubMed
  21. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009 Mar;122(3):248-256.e5. | PubMed
  22. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004 Dec 23;351(26):2683-93. | CrossRef | PubMed
  23. Csendes A, Papapietro K, Burgos AM, Lanzarini E, Canobra M. Efecto del bypass gástrico a largo plazo (7 a 10 años) en pacientes con obesidad severa y mórbida sobre el peso corporal, diabetes, dyslipidemia y desarrollo de anemia. Rev Med Chil. 2011 Nov;139(11):1414-20. Epub 2012 Feb 8. | CrossRef | PubMed
  24. Dixon JB, O’Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008 Jan 23;299(3):316-23. | CrossRef | PubMed
  25. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Laconelli A, Leccesi L. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012 Apr 26;366(17):1577-85. Epub 2012 Mar 26. | CrossRef | PubMed
  26. Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric Surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012 Apr 26;366(17):1567-76. Epub 2012 Mar 26. | PubMed
  27. American Diabetes Association. Standards of medical care in diabetes 2009. Diabetes Care. 2009 Jan;32 Suppl 1:S13-61. | PubMed
  28. Dixon J. Obesity and Diabetes: The impact of bariatric surgery on type-2 diabetes. World J Surg. 2009 Oct;33(10):2014-21. | CrossRef | PubMed
  29. Williamson DF, Thompson TJ, Thun M, Flanders D, Pamuk E, Byers T. Intentional weight loss and mortality among overweight individuals with diabetes. Diabetes Care. 2000 Oct;23(10):1499-504. | CrossRef | PubMed
  30. Pi-Sunyer X, Blackburn G, Brancati FL, Bray GA, Bright R, Clark JM, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007 Jun;30(6):1374-83. Epub 2007 Mar 15. | CrossRef | PubMed
  31. Pontiroli AE, Pizzocri P, Librenti MC, Vedani P, Marchi M, Cucchi E, et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab. 2002 Aug;87(8):3555-61. | CrossRef | PubMed
  32. Lee WJ, Wang W, Lee YC, Huang MT, Ser KH, Chen JC. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI>35 and <35 kg/m2. J Gastrointest Surg. 2008 May;12(5):945-52. Epub 2007 Oct 16. | CrossRef | PubMed
  33. DePaula AL, Macedo AL, Rassi N, Machado CA, Schraibman V, Silva LQ, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008 Mar;22(3):706-16. | CrossRef | PubMed
  34. Ramos AC, Galvão Neto MP, de Souza YM, Galvão M, Murakami AH, Silva AC, et al. Laparoscopic duodenal–jejunal exclusion in the treatment of type 2 diabetes mellitus in patients with BMI < 30 kg/m2 (LBMI). Obes Surg. 2009 Mar;19(3):307-12. Epub 2008 Nov 6. | CrossRef | PubMed
  35. Lanzarini E, Csendes A, Lembach H, Molina JC, Silva JL. Evolution of type 2 diabetes mellitus in non morbid gastrectomized patients with Roux en Y reconstruction: retrospective study. World J Surg. 2010 Sep;34(9):2098-102. | CrossRef | PubMed
  36. Fried M, Ribaric J, Buchwald J, Svacina S, Dolezalova K, Scopinaro N. Metabolic surgery for the treatment of type 2 diabetes in patients with BMI <35 Kg/mt2: an integrative review of early studies. Obes Surg. 2010 Jun;20(6):776-90. | CrossRef | PubMed
  37. Lanzarini E, Csendes A, Lembach H, Molina JC, Papapietro K, Araya V. Cirugía metabólica: ¿una nueva alternativa para el tratamiento de la diabetes mellitus tipo 2? Rev Hosp Clín Univ Chile. 2010;21:128-34.
  38. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007 Oct;142(4):621-32; discussion 632-5. | CrossRef | PubMed
  39. Nguyen NT, Hinojosa M, Fayad C, Varela E, Wilson SE. Use and outcomes of laparoscopic versus open gastric bypass at academic medical centers. J Am Coll Surg. 2007 Aug;205(2):248-55. Epub 2007 Jun 27. | CrossRef | PubMed
  40. DePaula AL, Macedo AL, Rassi N, Machado CA, Schraibman V, Silva LQ, et al. Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008 Mar;22(3):706-16. | CrossRef | PubMed